Overview Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia Status: Completed Trial end date: 2013-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate efficacy, safety of administered DWP05195 in Postherpetic Neuralgia. Phase: Phase 2 Details Lead Sponsor: Daewoong Pharmaceutical Co. LTD.